Human papillomavirus genotype-specific risks for cervical intraepithelial lesions-Reference-Cited by-同舟云学术

Human papillomavirus genotype-specific risks for cervical intraepithelial lesions

Published:2020-09-29 Issue:4 Volume:17 Page:972-981
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Nygård Mari¹,Hansen Bo T.¹,Kjaer Susanne K.²³,Hortlund Maria⁴⁵^ORCID,Tryggvadóttir Laufey⁶⁷,Munk Christian²,Lagheden Camilla⁴⁵,Sigurdardottir Lara G.⁶,Campbell Suzanne¹^ORCID,Liaw Kai-Li⁸,Dillner Joakim⁴⁵

Affiliation:

1. Department of Research, Cancer Registry of Norway, Oslo, Norway

2. Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark

3. Gynecologic Clinic, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark;

4. Formerly at WHO HPV LabNet Global Reference Laboratory, Clinical Microbiology, Skåne University Hospital, Malmö, Sweden

5. International HPV Reference Center, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden

6. Icelandic Cancer Registry, Icelandic Cancer Society, Reykjavik, Iceland

7. Faculty of Medicine, University of Iceland, Reykjavik, Iceland

8. Merck Research Laboratories, Merck Sharp & Dohme, Kenilworth, NJ, USA

Funder

Merck Sharp & Dohme Corp

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2020.1814097

Reference55 articles.

1. Papillomaviruses and cancer: from basic studies to clinical application

2. Equal Management of Equal Risks: What Should be Used as the Standard for Cervical Cancer Prevention?

3. European Commission. European guidelines for quality assurance in cervical cancer screening. In: editors, Anttila A, Arbyn M, De Vuyst H, Dillner J, Dillner L, Franceschi S, Patnick J, Ronco G, Segnan N, Suonio E, et al.Luxembourg: European Union; 2015. Available at https://publications.europa.eu/en/publication-detail/-/publication/a41a4c40-0626-4556-af5b-2619dd1d5ddc

4. Screening for Cervical Cancer With High-Risk Human Papillomavirus Testing

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cervical Cancer Screening: Impact of Human Papillomavirus mRNA Testing on Detecting High-Grade Lesions in Women with Normal Cytology;Women;2024-08-09

2. Enhancing Cervical Cancer Screening with 7-Type HPV mRNA E6/E7 Testing on Self-Collected Samples: Multicentric Insights from Mexico;Cancers;2024-07-08

3. Assessment of malignant potential for HPV types 16, 52, and 58 in the uterine cervix within a Korean cohort;Scientific Reports;2024-06-25

4. Comparative evaluation of HPV genotyping: A study on the performance concordance between Anyplex II HPV28 detection and Linear Array genotyping tests in nationwide studies in Brazil;PLOS ONE;2024-06-11

5. Characterization of human papillomavirus genotypes and their coverage in vaccine delivered to Ethiopian women;Scientific Reports;2024-04-04